Overview

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of a saquinavir (SQV) based regimen in HIV-1 infected Thai patients who have chronic indinavir (IDV) associated nephrotoxicity.
Phase:
Phase 2
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators:
Ministry of Health, Thailand
Roche Pharma AG
Treatments:
Saquinavir